Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer

BACKGROUND: Mesenchymal/metaplastic breast cancers (MpBCs) are often triple-negative (TNBC), and chemo-refractory, and can harbor phosphoinositide 3-kinase (PI3kinase) alterations; thus, therapy with mTor inhibitors may demonstrate activity. PATIENTS AND METHODS: Patients with mesenchymal/MpBC treat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Oncol
Egile Nagusiak: Moulder, S., Helgason, T., Janku, F., Wheler, J., Moroney, J., Booser, D., Albarracin, C., Morrow, P. K., Atkins, J., Koenig, K., Gilcrease, M., Kurzrock, R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267938/
https://ncbi.nlm.nih.gov/pubmed/25878190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv163
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak